Connection

Evangelos Terpos to Drug Resistance, Neoplasm

Back to Details
This is a "connection" page, showing publications Evangelos Terpos has written about Drug Resistance, Neoplasm.
Evangelos Terpos
Connection Strength
0.408
Drug Resistance, Neoplasm
  1. Bortezomib-based therapy for relapsed/refractory multiple myeloma in real-world medical practice. Eur J Haematol. 2018 Oct; 101(4):556-565.
    View in: PubMed
    Score: 0.140
  2. Optimizing therapy in bortezomib-exposed patients with multiple myeloma. Expert Rev Hematol. 2018 06; 11(6):463-469.
    View in: PubMed
    Score: 0.137
  3. Retreatment and prolonged therapy with subcutaneous bortezomib in patients with relapsed multiple myeloma: A randomized, controlled, phase III study. Eur J Haematol. 2018 Jan; 100(1):10-19.
    View in: PubMed
    Score: 0.132
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.